Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR was delisted on the 16th of April, 2019.
1 hedge funds and large institutions have $1K invested in Osiris Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 56 closing their positions.
98% less funds holding
Funds holding: 57 → 1 (-56)
100% less capital invested
Capital invested by funds: $130M → $1K (-$130M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 56
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$23.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$15.6M |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
-$11M |
| 4 |
Renaissance Technologies
New York
|
-$7.54M |
| 5 |
Millennium Management
New York
|
-$6.42M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Simplex Trading
Chicago,
Illinois
| – | -$57K | -3,049 | Closed |
|
52
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$41K | -2,182 | Closed |
|
|
RA
53
Royce & Associates
New York
| – | -$16K | -825 | Closed |
|
|
CFD
54
Creative Financial Designs
Kokomo,
Indiana
| – | -$13K | -667 | Closed |
|
|
DWA
55
Dorsey Wright & Associates
Pasadena,
California
| – | -$11K | -597 | Closed |
|
|
VFA
56
Valeo Financial Advisors
Carmel,
Indiana
| – | -$4K | -234 | Closed |
|
|
NCM
57
Next Capital Management
New York
| – | -$1K | -40 | Closed |
|
OSIR Hedge Fund Activity: Q2 2019 in Review
1 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q2 2019, worth a combined $1K — down 100% from $130M a quarter earlier.
Sellers outnumbered buyers: 56 funds closed out of OSIR and 0 opened new positions — a net loss of 56 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Alpine Associates Management, exiting entirely with an estimated $23.4M sold.
- 1 institutional investor held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q2 2019, down from 57 in Q1 2019.
- Funds reported $1K of Osiris Therapeutics, Inc. Common Stock stock for Q2 2019, down 100% quarter-over-quarter.
- 0 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q2 2019 and 56 closed out, a net change of -56 holders.
- The largest Osiris Therapeutics, Inc. Common Stock seller in Q2 2019 was Alpine Associates Management, an estimated $23.4M sold.
Based on aggregated 13F filings for Q2 2019.